Abstract:Advances in cancer immunotherapy have offered new hope for patients with metastatic disease. This unfolding success story has been exemplified by a growing arsenal of novel immunotherapeutics, including blocking antibodies targeting immune checkpoint pathways, cancer vaccines, and adoptive cell therapy (ACT). Nonetheless, clinical benefit remains highly variable and patient-specific, in part, because all immunotherapeutic regimens vitally hinge on the capacity of endogenous and/or adoptively transferred T-effector (Teff) cells, including chimeric antigen receptor (CAR) T cells, to home efficiently into tumor target tissue. Thus, defects intrinsic to the multi-step T-cell homing cascade have become an obvious, though significantly underappreciated contributor to immunotherapy resistance. Conspicuous have been low intralesional frequencies of tumor-infiltrating T-lymphocytes (TILs) below clinically beneficial threshold levels, and peripheral rather than deep lesional TIL infiltration. Therefore, a Teff cell ‘homing deficit’ may arguably represent a dominant factor responsible for ineffective immunotherapeutic outcomes, as tumors resistant to immune-targeted killing thrive in such permissive, immune-vacuous microenvironments. Fortunately, emerging data is shedding light into the diverse mechanisms of immune escape by which tumors restrict Teff cell trafficking and lesional penetrance. In this review, we scrutinize evolving knowledge on the molecular determinants of Teff cell navigation into tumors. By integrating recently described, though sporadic information of pivotal adhesive and chemokine homing signatures within the tumor microenvironment with better established paradigms of T-cell trafficking under homeostatic or infectious disease scenarios, we seek to refine currently incomplete models of Teff cell entry into tumor tissue. We further summarize how cancers thwart homing to escape immune-mediated destruction and raise awareness of the potential impact of immune checkpoint blockers on Teff cell homing. Finally, we speculate on innovative therapeutic opportunities for augmenting Teff cell homing capabilities to improve immunotherapy-based tumor eradication in cancer patients, with special focus on malignant melanoma.

Barriers to immune cell infiltration in tumors

Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity

Hurdles to Lymphocyte Trafficking in the Tumor Microenvironment: Implications for Effective Immunotherapy

T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy

Tumor Immune Checkpoints and Their Associated Inhibitors

Beyond the barrier: the immune-inspired pathways of tumor extravasation

Immune Cell Migration to Cancer

Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy

Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy

Cell-mediated barriers in cancer immunosurveillance

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy

Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories

Vascular Microenvironment, Tumor Immunity and Immunotherapy

Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy

Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies

Perspectives on Vascular Regulation of Mechanisms Controlling Selective Immune Cell Function in the Tumor Immune Response

A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies

Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response

Cracking the Codes behind Cancer Cells' Immune Evasion